Carsten Boess
Director/Board Member presso ROCKET PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Karl Peggs | M | 57 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 8 anni |
| Troy Wilson | M | 55 | 12 anni | |
| Edwin Moses | M | 69 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 anni |
| Lars Fruergaard Jorgensen | M | 58 | 33 anni | |
| Stephen Biggar | M | 53 | 13 anni | |
| Eben Tessari | M | 42 | 10 anni | |
| Iraj Ali | M | 48 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 anni |
| David Southwell | M | 63 | 10 anni | |
| Barry D. Quart | M | 67 | 12 anni | |
| Sarah Boyce | F | 52 | 5 anni | |
| Eric B. Mosbrooker | M | 46 | 3 anni | |
| John Militello | M | 50 | 6 anni | |
| Derek DiRocco | M | 43 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 4 anni |
| Michael Megna | M | 53 | 6 anni | |
| Rod Wong | M | 47 | 6 anni | |
| Mark Ragosa | M | 50 | 6 anni | |
| Kathleen Gallagher | F | - | 3 anni | |
| Arthur Levin | M | 70 | 11 anni | |
| Gaurav D. Shah | M | 49 | 6 anni | |
| John W. Wallen | M | 66 | 12 anni | |
| Sanj Patel | M | 54 | 9 anni | |
| Michael Giordano | M | 66 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 anni |
| Tracey McCain | F | 56 | 6 anni | |
| Felix Baker | M | 55 | 9 anni | |
| Kinnari Patel | M | 46 | 6 anni | |
| Sergio Quezada | M | 49 | 4 anni | |
| Martin Wilson | M | 47 | 3 anni | |
| Jonathan Schwartz | M | 60 | 8 anni | |
| R. Woods | M | 57 | 1 anni | |
| Melissa Manno | F | - | 9 anni | |
| Gayatri R. Rao | M | - | 6 anni | |
| Tamar Thompson | F | 50 | 3 anni | |
| Daniel Hood | M | - | - | |
| Noreen Henig | M | 59 | 5 anni | |
| Mark White | M | 57 | 1 anni | |
| Kim Popovits | F | 65 | 6 anni | |
| Thomas Malley | M | 55 | 8 anni | |
| Edward Kaye | M | 74 | 5 anni | |
| Richard Levy | M | 66 | 5 anni | |
| Pedro Granadillo | M | 77 | 6 anni | |
| Naveen Yalamanchi | M | 47 | 6 anni | |
| Jean J. Kim | F | 50 | 3 anni | |
| Michael MacLean | M | 58 | 4 anni | |
| Gotham Makker | M | 50 | 6 anni | |
| Bernhard R. M. Ehmer | M | 69 | 2 anni | |
| Henrik Ehlers Wulff | M | 54 | 25 anni | |
| Karsten Munk Knudsen | M | 53 | 25 anni | |
| Fady Malik | M | 59 | 2 anni | |
| Margareta Elisabeth Björk | M | 63 | 4 anni | |
| Tariq Ahmed | M | - | 4 anni | |
| Edward Samuel | M | - | 2 anni | |
| Liz Elmhirst | F | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
| Shree Patel | M | - | - | |
| James Taylor | M | - | 2 anni | |
| Robert Coutts | M | 40 | 4 anni | |
| Carlos Martin | M | - | - | |
| Ross Moat | M | 43 | 5 anni | |
| Rogier Rooswinkel | M | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
| Dara Henry | M | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
| Martin Lange | M | 54 | 22 anni | |
| Martina Struck | M | - | 6 anni | |
| Martin Murphy | M | 55 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
| Julie O'Neill | F | 58 | 3 anni | |
| Steven G. Hughes | M | 57 | 2 anni | |
| Katrine Sperling | F | - | 22 anni | |
| Camilla Sylvest | F | 52 | 28 anni | |
| Elisa Petris | M | 45 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 8 anni |
| Maziar Mike Doustdar | M | 54 | 32 anni | |
| John Paolini | M | 59 | 8 anni | |
| Brooks Rahmer | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Christopher Heberlig | M | 49 | 12 anni | |
| Thomas Beetham | M | 55 | 8 anni | |
| Stephen Mahoney | M | 53 | 7 anni | |
| Brian Batchelder | M | - | - | |
| Mayur Kasetty | M | - | 4 anni | |
| Rasmus Holm-Jorgensen | M | 53 | 11 anni | |
| Jakob Riis | M | 58 | 21 anni | |
| Todd Brady | M | 45 | 5 anni | |
| Deirdre O’Donnell | F | - | - | |
| Brendan Classon | M | - | - | |
| Allison Dorval | F | 48 | 7 anni | |
| Michael Martin | M | 50 | 5 anni | |
| Lynn A. Taylor | F | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Mark Goldberg | M | 69 | 6 anni | |
| Thomas Tisch | M | 69 | 3 anni | |
| Steven T. Sobieski | M | 66 | 10 anni | |
| Carsten Hellmann | M | 60 | - | |
| Joseph Zakrzewski | M | 60 | 9 anni | |
| John T. Garibotto | M | 59 | 8 anni | |
| Mads Krogsgaard Thomsen | M | 63 | 30 anni | |
| Jesper Brandgaard | M | 60 | 20 anni | |
| Sten Scheibye | M | 72 | 10 anni | |
| Kurt Anker Nielsen | M | 78 | 13 anni | |
| Stephen Davis | M | 63 | 4 anni | |
| Peter Wirth | M | 73 | 3 anni | |
| Sally Crawford | F | 70 | 13 anni | |
| Lars Robert Boesgaard | M | 55 | 5 anni | |
| Larry L. Mathis | M | 80 | 10 anni | |
| Regina O. Sommer | F | 66 | 9 anni | |
| Claudine Prowse | M | - | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 68 | 68.00% |
| Regno Unito | 19 | 19.00% |
| Danimarca | 13 | 13.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Carsten Boess
- Contatti personali
